The logic here is different but equally valid
What to do: Stay consistent
The intermittent approach in longevity research, three times weekly, suggests that continuous daily dosing may not be necessary or optimal
Often worth exploring for Adults noticing age-related decline in recovery, sleep, or energy Active people who want a clinician-guided plan instead of self-directed use Patients who want their protocol built on labs, not guesswork People already dialing in nutrition, training, and sleep who want added support Who should avoid CJC-1295 and Ipamorelin
Athletes and those focused on physical performance may benefit from DSIP protocols timed around training demands
Microdosing Semaglutide vs Tirzepatide Tirzepatide (brand names Mounjaro and Zepbound) has become the go-to comparison for anyone weighing microdosing options